This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Speaker Programs Summit
March 3-5, 2025
The Logan HotelPhiladelphia, PA

David Caponera
Executive Director, Patient Advocacy, Communication, Public Affairs, and Sustainability at Novo Nordisk


David Caponera, Executive Director, Patient Advocacy, Novo Nordisk

A patient focused leader who has the privilege to bridge the patient perspective and company goals to support the dynamics in today’s healthcare arena by being the Patient Advocacy liaison with extensive rare disorders experience in which specialty / orphan products are being developed and implemented. A Registered Respiratory Therapist who has worked clinically and then moved into the world of Managed Care, Specialty Pharmacy, and landing in biotechnology with a focus on ultra-rare disorders having experience at Genzyme, Amicus Therapeutics, Pfizer, Aegerion, Catalyst Pharmaceuticals, and Dicerna Pharmaceuticals.

Agenda Sessions

  • [Panel] Large, Mid-Sized, Small Pharma and Medical Device — Comparing the Unique Challenges